MRC Epidemiology Unit

  • Home
  • MRC Epidemiology Unit

MRC Epidemiology Unit Obesity, type 2 diabetes and related metabolic disorders present a major and growing global public health challenge.

The MRC Epidemiology Unit investigates the individual and combined effects of genetic, developmental, behavioural & environmental factors that cause obesity, type 2 diabetes and to develop and evaluate strategies to prevent them and their consequences. These disorders result from a complex interplay between genetic, developmental, behavioural and environmental factors that operate throughout life. The mission of the MRC Epidemiology Unit is to investigate the individual and combined effects of these factors and to develop and evaluate strategies to prevent these diseases and their consequences. In this way, we are working to improve the health of people in the UK and around the world. We are a Medical Research Council Unit embedded as a department of the University of Cambridge School of Clinical Medicine. The Unit is part of the Wellcome – MRC Institute of Metabolic Science (IMS) on the Cambridge Biomedical Campus, where the principle offices and laboratories of the Unit are physically located. Unit Director Professor Nick Wareham is Co-Director of the IMS with Professor Sir Stephen O’Rahilly. Being embedded in the IMS is critical to our aspiration to follow up associations between exposures and metabolic disease outcomes to determine possible causality and mechanisms. The Unit is also a part of Cambridge Population Health Sciences, a three department partnership of the Department of Public Health and Primary Care and the MRC Biostatistics Unit. Collectively, the Partnership pursues a wide range of research across epidemiology, biostatistics, population health and primary care, and delivers the Masters courses in Population Health Sciences. We are delivering on our mission through eight High Level Objectives which connect all our research programmes and infrastructure.

- To investigate the causes of obesity, diabetes and related metabolic disorders
- To develop understanding of mechanisms identified by population-based studies
- To develop and evaluate individual level approaches to the prevention of diabetes, obesity and related metabolic disorders in children and adults
- To inform, develop and evaluate population-based approaches to improving health
- To develop new methods, resources and tools for epidemiological and public health research
- To investigate approaches to improving global health, particularly in low and middle income countries
- To build capacity for conducting, understanding and using local, national, and international epidemiology and public health research
- To contribute to the translation of research evidence into policy and practice

The main objectives of each individual research programme are mapped to one or more of these High Level Objectives, which therefore provide a unifying framework to illustrate and augment the cross-links and collaborations between programmes.

Recruitment and data collection for Fenland phase 3 study is now complete. We are grateful to the more than 5,000 Fenlan...
08/12/2025

Recruitment and data collection for Fenland phase 3 study is now complete. We are grateful to the more than 5,000 Fenland Study participants who took part in this phase of the study.

A total of 4,973 participants came for a clinical visit, provided questionnaire responses, and wore a physical activity monitor. A further 73 provided questionnaire data and wore a physical activity monitor without attending a visit.

We are working hard to make the Fenland 3 data available for release as soon as we can. Lab results, anthropometry variables, and raw questionnaire variables are now available for request. Liver ultrasound, medications, dietary intake and physical activity data will be made available over the next few months. Keep an eye on the Fenland Study Data Sharing page for updates on when we expect datasets to become available.

We are grateful to everyone who has participated in the Fenland Study, which marks its 20th anniversary this year and has contributed to more than 110 publications. We look forward to continuing to work with them in future, and to reporting back to them on the continued growth of the impact of the research that they have contributed to.

Congratulations to Dr Cara Ruggiero, who was recently named runner-up for the British Nutrition Foundation Drummond Earl...
05/12/2025

Congratulations to Dr Cara Ruggiero, who was recently named runner-up for the British Nutrition Foundation Drummond Early Career Scientist Award 2025, which was presented at the BNF Annual Conference held at the Royal College of Physicians in central London on Tuesday, 25th November 2025.

A new study led by Dr Robert Luben, utilizing data from studies including UK Biobank and EPIC-Norfolk, has identified ge...
04/12/2025

A new study led by Dr Robert Luben, utilizing data from studies including UK Biobank and EPIC-Norfolk, has identified genetic risk factors for primary angle-closure glaucoma (PACG) in European populations, shedding new light on the genetic underpinnings of this condition across different ancestry groups.

In PACG the eye's drainage angle becomes blocked, leading to increased pressure in the eye and damage to the optic nerve. It is a leading cause of blindness in older adults, and while most cases are reported in East Asian populations, an estimated 2.6 million people of European ancestry have PACG. Previous genome-wide association studies (GWAS) identified eight genetic loci associated with PACG risk in Asian populations. However, the extent to which these genetic risk factors apply to other populations has remained unclear.

In this new study, researchers conducted a discovery GWAS for PACG in European populations using data from the UK Biobank, identifying five genomic regions that were associated with PACG, including two loci previously identified in Asian populations. They successfully replicated their findings in six independent European populations and then compared these results with data from 14 Asian population cohorts.

The meta-analysis that statistically combined data from the combined European and Asian populationcohorts identified six additional novel loci, all previously associated with refractive error, a common eye condition where the eye cannot focus light properly on the retina, leading to blurred vision

Using Mendelian randomisation, the study provided strong evidence for a causal role of shorter axial length of the eye and hypermetropic (farsighted) refractive error in the development of PACG. Furthermore, a polygenic risk score derived from the European ancestry meta-analysis showed significant associations with quantitative ocular traits, such as a shallower anterior chamber and higher intraocular pressure, in the independent EPIC-Norfolk cohort.

In a subsequent multi-ancestry meta-analysis of 21 European and Asian cohorts, the researchers identified 12 additional novel loci. Most notably, the study showed that genetic factors associated with a darker iris eye axial length and hypermetropia confer risk for primary angle-closure glaucoma. Genetic factors associated with a darker iris were associated with PACG in European but not Asian populations, potentially reflecting the more homogeneous eye colour in Asian populations, and eye colour may be a surrogate for other genetic risk factors such as iris thickness.

This research not only advances our understanding of the genetic basis of PACG, opening up the possibility of targeted screening efforts for this blinding disease, but also highlights the importance of considering genetic diversity across populations in the study of complex diseases.

"A key strength [of the guidance] is the emphasis on combining medication with behavioural support and on the need for e...
02/12/2025

"A key strength [of the guidance] is the emphasis on combining medication with behavioural support and on the need for equitable access, rather than presenting drugs as a stand-alone solution.

"It clearly recognises obesity as a chronic, progressive, and relapsing disease that requires long-term, integrated management rather than short-term treatment "

Dr Marie Spreckley comments on new WHO guidance on weight loss drugs in a Euronews article https://buff.ly/BEypph6

Dr Spreckley leads the AMPLIFY study, exploring the lived experiences of people using, or who have recently stopped, incretin-based weight loss therapies, to better understand how to support them with information and wrap-around support.

Find out more about Amplify at https://buff.ly/AxR0QqR

Congratulations to Kelly Kokka and James Woodcock on being awarded funding for their project using articifial intelligen...
01/12/2025

Congratulations to Kelly Kokka and James Woodcock on being awarded funding for their project using articifial intelligence (AI) to help planners create healthier and more sustainable cities by analysing street camera images and travel patterns across 45 cities worldwide to create detailed neighbourhood maps showing how people move.

Theirs is one of 15 groundbreaking projects funded by the Accelerate Programme for Scientific Discovery and Cambridge Centre for Data-Driven Discovery that will use AI to tackle some of the most pressing challenges in science and society.

https://buff.ly/Hn8kZBY

Join our next online Bradford Hill Seminar with Dr Muin J. Khoury, who until recently led the Office of Public Health Ge...
01/12/2025

Join our next online Bradford Hill Seminar with Dr Muin J. Khoury, who until recently led the Office of Public Health Genomics at the CDC, and will discuss:

From Genes to Public Health: The Journey Continues!

📅 Wed 10 December, 1 PM (UK)

Info and registration - https://buff.ly/i1j3aoU

The Unit has donated equipment to Medical Aid International. The social enterprise works to advance patient care in low ...
28/11/2025

The Unit has donated equipment to Medical Aid International. The social enterprise works to advance patient care in low and middle income countries (LMICs) through long-term, sustainable change.

We are proud to be able to help the enterprise’s work by donating manually operated clinical couches, automatic BP monitors, ECG machines and clinical trolleys.

As the Health Secretary announces that the Soft-Drinks Industry Levy (SDIL) will be extended to cover milkshakes and pre...
25/11/2025

As the Health Secretary announces that the Soft-Drinks Industry Levy (SDIL) will be extended to cover milkshakes and pre-packaged lattes, it's worth taking a look back at a few findings from the evaluation of the SDIL undertaken by Professor Martin White and colleagues.

An analysis of UK National Diet and Nutrition Survey data led by Dr Nina Rogers and Professor Jean Adams found daily free sugar intake fell by 5g in children and 11g in adults following the announcement of the SDIL in 2016.

https://buff.ly/xLDWsTw

Research by Dr Nina Rogers and Professor David Conway indicates the SDIL may have reduced tooth removal in under 18's due to tooth decay by 12%, saving >5,500 hospital admissions for tooth decay with the largest reductions in children aged 0-9 years.

https://buff.ly/v7cwv90

Despite widespread industry fears the SDIL would harm their businesses, research led by Dr Cherry Law found that leading UK soft drinks companies continued to experience positive growth in their share prices during its implementation.

https://buff.ly/i57wGtr

Looking for reliable, high-quality biological sample processing and storage services? The BioRepository at the MRC Epide...
25/11/2025

Looking for reliable, high-quality biological sample processing and storage services?

The BioRepository at the MRC Epidemiology Unit has supported research studies and trials since 2017, with a dedicated team and state-of-the-art facilities at the Cambridge Biomedical Campus and Research Park.

We offer:
✅ Blood fractionation, DNA extraction & QC
✅ Secure ULT storage (-80°C, -20°C, LN tanks)
✅ HTA-licensed operations and full sample traceability via LabVantage LIMS
✅ Fast sample retrieval and dispatch
📍 Based in Cambridge, we’re here to support academic and industry partners alike.

At the BioRepository, we're proud to combine scientific precision with environmental responsibility. Our newly expanded Nordic ULT Freezer System offers:

🔒 100% backup for sample security
🌡️ 24/7 monitoring & telemetry
🌍 Significant energy savings and reduced carbon footprint

📨 Get in touch for a tailored quote: BioRepManager@mrc-epid.cam.ac.uk

Website: https://buff.ly/59J0cNp

Can we trust the science of nutrition?That was the question asked of the Unit’s Professor Nita Forouhi and others on an ...
24/11/2025

Can we trust the science of nutrition?

That was the question asked of the Unit’s Professor Nita Forouhi and others on an expert panel for the BBC’s A Question of Science.

Prof. Brian Cox and guests dive into the complex world of diet, nutrition & food choices.

Listen - https://buff.ly/DSDX2UY

Analysis of changes in physical activity and diet quality in 7,256 Fenland Study participants has found that while impro...
21/11/2025

Analysis of changes in physical activity and diet quality in 7,256 Fenland Study participants has found that while improved diet quality and increased physical activity were each independently associated with lower increases in body fat, the greatest benefits were achieved by combining both.

The analysis of data from Fenland participants, who had a mean age of 49 years at baseline and 56 years at follow-up, was led by MRC Epidemiology Unit researchers Dr Shayan Aryannezhad and Professor Nita Forouhi.

At both baseline and at follow-up seven years later, Fenland participants’ diet quality was assessed by the degree of adherence to the Mediterranean diet pattern using a food frequency questionnaire, and the quantity and distribution of body fat was measured objectively using DEXA.

Using DEXA enabled the researchers to demonstrate that visceral fat stored around the organs in the abdomen, which is linked to a higher risk of metabolic diseases, was particularly responsive to the changes in health behaviours.

The results highlight the health benefit from making small, sustained changes to behaviours, and Professor Forouhi urges policymakers to seek to alter the food and physical activity environments to make healthier choices more accessible for all.

"Nutrition must no longer remain a missing pillar in obesity management medication care."Dr Marie Spreckley, Dr Cara Rug...
17/11/2025

"Nutrition must no longer remain a missing pillar in obesity management medication care."

Dr Marie Spreckley, Dr Cara Ruggiero and Dr Adrian Brown discuss lessons from bariatric interventions on the nutritional support needed for individuakls undergoing GLP-1 receptor agonist assisted weight loss therapy.

Read the International Journal of Obesity paper at https://buff.ly/wpBiBEt

Dr Spreckley is now leading the new AMPLIFY study that seeks to understand how people experience GLP-1 receptor agonist-based therapies, such as semaglutide and tirzepatide. This will inform guidance and wrap-around care models for people using these weight management medications.

Read our recent news post on the AMPLIFY Study at https://buff.ly/o6auZ0q

Address

MRC Epidemiology Unit, University Of Cambridge School Of Clinical Medicine, Box 285 Institute Of Metabolic Science, Cambridge Biomedical Campus

CB20QQ

Alerts

Be the first to know and let us send you an email when MRC Epidemiology Unit posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MRC Epidemiology Unit:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram